Model Analyses Methods
We formulate our models so that, in the absence of intervention, the equilibrium prevalence and incidence in the high- and low-risk groups are the same for all values of μ. Epidemiologists commonly assess infection incidence or prevalence in high- and low-risk groups but they do not assess the effects of mixing on these infection levels. By examining identical infection levels at different mixing settings, we make clear the importance of such assessment. The formulation that allows us to do this is presented in the supporting online material.
We make 2 comparisons of the effects of interventions focused on the high-risk group to interventions affecting everyone evenly. First, we compare the minimal total effects needed to stop transmission in the population. This level is determined by finding effects that get the basic reproduction number just below one. Second, we compare the effects on endemic infection levels of small interventions using equation 1 to equalize the focused and unfocused interventions.
The outcome we examine for the second comparison is the relative reduction in total population incidence (RRInc).
πH and πL are the endemic equilibrium incidence in the high- and low-risk group before intervention and ρH and ρL are the endemic equilibrium incidence after intervention. The equilibrium values are found by numeric solution of the differential equations underlying the model.
Intervention Effects for Noninfectious Diseases
For noninfectious diseases, the population RRInc is unaffected by who mixes with whom. At α = 0.05, πL = 0.03, εN = 5 (thus πH = εN πL = 0.15), the preintervention population incidence at equilibrium is
When Y = 0.05 the equilibrium incidence after the focused intervention, ρH, is εN ρL (1−Y). The population incidence at equilibrium is thus
For the unfocused intervention, the population incidence at equilibrium remains the same at
Thus, RRInc = 0.0104 for both the focused and unfocused interventions.
Patterns of Transmission Model Parameters Generating the Same Incidence in Both Groups
Risk factors affecting infection transmission act during interactions between individuals rather than directly on individuals like in the calculations shown here. Thus, we need a transmission model to analyze risk factor effects. To help the reader understand how the transmission model generates fixed endemic incidence as the mixing parameter is varied, we present in Figure 2 the parameter values for c and β that generate incidences of 0.15 and 0.03 in the absence of any intervention at each mixing level μ.
First consider high-risk generated by increased susceptibility. As μ increases, more high-risk individuals contact low-risk individuals. This situation would raise the incidence in the low-risk group. Consequently, we reduce the contact rate to maintain the low-risk group incidence at 0.03. The incidence in the high-risk group would fall both because fewer of their contacts will be infected and because the c is falling. Thus, to keep the high-risk group incidence at 0.15, the susceptibility of this must increase as μ increases. This is accomplished by increasing the εS parameter.
When contagiousness is generating the high risk, a similar phenomenon takes place. The low-risk group experiences even greater increased risk with each increase in mixing because the high-risk group is more contagious. Thus, the contact parameter must decrease even more than when susceptibility generates high risk. In a corresponding fashion, the contagiousness parameter also has to compensate more because it is acting on a smaller fraction of the contacts of the high-risk group. For contagiousness to generate high risk in a group with increased contagiousness, assortative mixing is required. That is why contagiousness risk factors are not plotted at the higher end of the scale in the figures. More details on the formulations of c, εS, and εC are presented in the supporting online material.
Effort Required to Eradicate Infection
For each of the 8 interventions in Table 2, we determined the average percentage reduction in either susceptibility or contagiousness per person in the overall population that is required to eradicate infection given initial equilibrium incidence values of 0.15 and 0.03 and 5% of the population in the 0.15 group. The results are seen in Figure 3. Note that interventions focused on the high-risk group require much less effort to achieve eradication than the unfocused interventions over most of the mixing range. The unfocused program has a slight advantage only at the very high end of the mixing scale.
Effects of 5% Risk Reductions in the High-Risk Group or an Equivalent Amount in Everyone
To understand better how these various factors change the dynamics of an intervention, we examine the effects of small interventions equal to those for noninfectious diseases. The interventions are small enough so that they never eradicate infection. In Figure 4, we examine the population relative incidence reduction for the focused and unfocused interventions, given the same starting values of 0.15 and 0.03 incidence and 5% in the high-risk group. Like in the eradication analysis, focused interventions have advantages over unfocused interventions. This analysis, however, reveals effects that the eradication analysis does not.
First, note that at every point on the mixing scale, both focused and unfocused intervention effects are considerably greater than the approximately 1% effect seen for noninfectious diseases. This larger effect for infectious diseases occurs because each direct effect for infectious disease control results in indirect effects both on those who do and who do not directly receive benefits from the intervention.
Second, note that at the completely assortative point on the mixing scale, the unfocused interventions have a very small advantage. That advantage occurs because the low-incidence population has a basic reproduction number (R0) closer to one than the high-incidence population and, as one gets closer to an R0 of one, eradication is easier to achieve.
Third, note that the contagiousness interventions in the high-risk group are more effective than the susceptibility interventions regardless of whether susceptibility or contagiousness has generated the high risk. This is due to “differential consumption of susceptibles.” When the high-risk group receives a susceptibility intervention, there is now a reduced differential between the rates at which they and the low-risk group become infected. Thus, at equilibrium, the high-risk-group susceptibles are not consumed as fast, and the consumption of susceptibles has less of an effect on equilibrium levels of infection. With the contagiousness intervention, the consumption of susceptibles is unchanged. Thus, the contagiousness intervention has the larger effect. The reason there is no difference between contagiousness and susceptibility interventions with regard to eradication levels is because no susceptibles are being consumed at the point of eradication.
Fourth, note that focused interventions have greater effects than unfocused programs over most of the mixing range. Unfocused programs compete reasonably with the focused programs only at proportionate mixing levels (μ = 0.95) or higher. In the additive joint effects formulation presented in the supporting online material, the differences between focused and unfocused interventions extend further up the mixing scale.
System Parameter Sensitivities
We explored a range of parameter settings and found some interesting implications. These did not change our general conclusions. When the fraction of the population in the high-risk group is raised to 10%, the unfocused interventions look much like those in Figure 4, but they rise faster and surpass the focused programs at slightly lower levels of mixing. When incidence rates are lowered but have the same ratio between high-risk and low-risk groups, the differential between focused and unfocused interventions increases markedly (regardless of whether susceptibility or contagiousness causes the high risk). However, even in this case, at the upper end of the mixing scale, the unfocused programs surpass the focused programs.
When susceptibility causes the increased risk, at 5-fold higher incidence levels or at 5-fold higher prevalence levels (determined by a 5-times longer duration of infection), there is less difference at the lower end of the mixing scale between focused and unfocused programs. Furthermore, the unfocused programs surpass the focused programs at a somewhat lower level of mixing. In contrast, when contagiousness generates the high risk, there are greater differences than those in Figure 4.
When the difference between high-risk-group and low-risk-group incidence is diminished, the effects of focused interventions are increased when contagiousness is generating the high risk, and they are never surpassed by unfocused infections. The effects of all other programs, however, have the same relationships as in Figure 4 but with lower effects for the focused programs. In this case, the curves of the unfocused programs again edge above those of the focused programs at the high end of the mixing scale.
We have demonstrated that focusing infectious disease control efforts on high-risk groups has a considerable advantage that is not seen for noninfectious diseases. The degree of mixing between high-risk and low-risk groups strongly modifies this advantage. We only examined infections that do not lead to acquired immunity, in which duration of infection is always constant and where contacts are symmetric. In work not reported here, we have found that the general conclusion about the increased effects of focused interventions for infectious diseases also holds for risk factors that affect contact rates or infection duration. The effects of risk factors affecting the duration of infection are similar to those affecting contagiousness.
We have also demonstrated that controlling contagiousness in high-risk groups reduces population levels of infection more than reducing susceptibility or shortening the duration of infection. The greater effects of reducing contagiousness are because differential consumption of susceptibles reduces the effects of susceptibility or infection-duration reductions. Our preliminary explorations indicate that this effect will be even stronger for infections that induce acquired immunity. It seems likely to us that there is more controllable variation in risk factors affecting contagiousness than there is in risk factors affecting susceptibility. This variation, together with the greater effects of reducing contagiousness, should lead infection control to focus on contagiousness. Standard epidemiologic analyses, however, focus on comparing the risk experience of different individuals. They are thus completely incapable of detecting contagiousness effects and consequently do not lead public health efforts in the most productive direction.
To overcome this deficiency, studies should be designed in social units where transmission occurs. The analysis of such studies should use transmission models rather than individual risk-based models that assume away transmission.
Specific Infection Control Implications
Consider the control of HIV transmission in developing countries with the limited resources available. To best protect all the people, our results suggest that it may prove wise to focus on controlling the contagiousness of groups with high risk. Prioritization of contact-tracing efforts, treatment resources, and behavior change efforts should take this into account.
The best way to stop transmission, however, may be vaccines that reduce the contagiousness of early HIV infection. High contagiousness during early HIV infection in high-risk groups has been shown theoretically to have an especially amplifying effect on population circulation of HIV.5,6 Consequently, vaccines that lower contagiousness only moderately during the crucial early stage of infection might have dramatic effects on transmission at the population level. Thus, vaccine trials must be designed in a way to detect such effects. There are many ways to do this.7–17 In each, a transmission unit rather than an individual must be the unit of study. Retrospective partnership trials7 could be an effective trial design in populations in which partnership change is frequent. Where concurrent partnerships are more frequent, prospective designs could be used.8,13,14 Separate populations represent another transmission unit that can be used.17
Another vaccine issue relates to the control of nontypeable Haemophilus influenzae (NTHi), a cause of acute otitis media, bronchitis, sinusitis, and pneumonia. The endemic prevalence of this agent is high. Consequently, most pediatricians and vaccinologists have assumed that an NTHi vaccine must protect against disease given colonization. We have shown that, in fact, vaccine protection that reduces transmission will reduce otitis more than vaccine protection against disease given colonization.18 Immunity effects that reduce contagiousness of colonized individuals can have very dramatic effects on population levels of infection. NTHi vaccine trials must thus have transmission units as their basic study entities.
Another example relates to Cryptosporidium control in developed countries. Because of the devastating effect of this infection on people with AIDS, control of Cryptosporidium transmission through water is becoming more urgent. However, the costs of different approaches to control of water contamination can run into many billions of dollars. We have modeled this issue.19,20 The role that water plays in a transmission system depends heavily on how much transmission is occurring through other modes. A water intervention is a costly way to achieve a small decrease in transmission risk evenly across an entire population. An implication of our analysis here is that cheaper interventions affecting hygiene in high-transmission groups could be more effective in reducing population levels of infection than improved water treatment. On the other hand, we have shown that the disseminating role of water transmission might greatly amplify its importance.21 General insights like those we seek to present in this article cannot resolve this sort of issue. However, such insights do make it evident that a formal evaluation of transmission effects for various focused or general interventions should be a key element contributing to decisions on Cryptosporidium control efforts.
The analysis presented here extends analyses pursued by others. In their classic text, Anderson and May22 lay the foundations of intervention strategies for heterogeneous populations. Their chapter 9 introduces matrices of “Who Acquires Infection From Whom,” which present the effective contact rates between groups. The analysis we present elaborates on this foundation by explicitly formulating causes for high risk and by specifying interventions affecting either susceptibility or contagiousness.
Woolhouse et al23 similarly build on Anderson and May. Arguing that “heterogeneous contact is likely to be an important determinant of the epidemiology of vector-borne diseases and STDs,” they analyze 10 datasets of vectorborne diseases and HIV. They conclude that “control programs targeted at the ‘core’ 20% group are potentially highly effective.” They close with a list of “higher-order heterogeneities” that may further increase R 0. These include “patterns of contact between highly sexually active and less sexually active groups” in this list (the only one without references). We have shown here how and why that is the case.
1.Haddix AC, Teutsch SM, Shaffer PA, Dunet DO. Prevention Effectiveness: A Guide to Decision Analysis and Economic Evaluation
. New York: Oxford University Press; 1996.
2.Rose G. Sick individuals and sick populations. Int J Epidemiol
3.Koopman J. Modeling infection transmission. Annu Rev Public Health
4.Koopman JS, Weed DL. Epigenesis theory: a mathematical model relating causal concepts of pathogenesis in individuals to disease patterns in populations. Am J Epidemiol
5.Jacquez JA, Koopman JS, Simon CP, Longini IM Jr. Role of the primary infection in epidemics of HIV infection in gay cohorts. J Acquir Immun Defic Syndr
6.Koopman JS, Jacquez JA, Welch GW, et al. The role of early HIV infection in the spread of HIV through populations. J Acquir Immun Defic Syndr Hum Retrovirol
7.Adams AL, Chick SE, Barth-Jones DC, Koopman JS. Stimulation to evaluate HIV vaccine trial designs. Simulation
8.Datta S, Halloran ME, Longini IM Jr. Augmented HIV vaccine trial design for estimating reduction in infectiousness and protective efficacy. Stat Med
9.Datta S, Halloran ME, Longini IM Jr. Efficiency of estimating vaccine efficacy for susceptibility and infectiousness: randomization by individual versus household. Biometrics
10.Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol
11.Halloran ME, Longini IM Jr, Struchiner CJ. Design and interpretation of vaccine field studies. Epidemiol Rev
12.Halloran ME, Longini IM Jr. Using validation sets for outcomes and exposure to infection in vaccine field studies. Am J Epidemiol
13.Koopman JS, Little RJ. Assessing HIV vaccine effects. Am J Epidemiol
14.Longini IM Jr, Datta S, Halloran ME. Measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV-1 vaccines. J Acquir Immun Defic Syndr Hum Retrovirol
15.Longini IM Jr, Sagatelian K, Rida WN, Halloran ME. Optimal vaccine trial design when estimating vaccine efficacy for susceptibility and infectiousness from multiple populations [erratum appears in Stat Med
. 1999;18:890]. Stat Med
16.Longini IM Jr, Hudgens MG, Halloran ME, Sagatelian K. A Markov model for measuring vaccine efficacy for both susceptibility to infection and reduction in infectiousness for prophylactic HIV vaccines. Stat Med
17.Longini IM Jr, Halloran ME, Nizam A. Model-based estimation of vaccine effects from community vaccine trials. Stat Med
18.Koopman JS, Lin X, Chick SE, Gilsdorf JR. Transmission model analysis of non-typeable Haemophilus influenzae
. In: Brandeau ML, Pierskalla B, Sainfort F, eds. Handbook of Operations Research/Management Science Applications in Health Care.
19.Chick SE, Koopman JS, Soorapanth S, Brown ME. Infection transmission system models for microbial risk assessment. Sci Total Environ
20.Soorapanth S, Chick SE, Koopman JS. Simulation of stochastic infection transmission models designed to inform water treatment decisions. In: Giambiasi N, Frydman C, eds. Proceedings of the European Simulation Symposium Society for Computer Simulation
21.Koopman JS, Chick SE, Simon CP, Riolo CS, Jacquez G. Stochastic effects on endemic infection levels of disseminating versus local contacts. Math Biosci
22.Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control.
Oxford University Press; 1991.
23.Woolhouse ME, Dye C, Etard JF, et al. Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A
Supplemental Digital Content
Copyright © 2005 Wolters Kluwer Health, Inc. All rights reserved.